Recombinant Human TLR7 Protein，His

Toll-like receptor 7 (TLR7) is a key component of the innate immune system, primarily involved in recognizing single-stranded RNA from viruses and initiating immune responses. It plays a crucial role in detecting viral infections and activating dendritic cells, which further stimulate adaptive immunity. Research on TLR7 has garnered significant attention due to its potential implications in vaccine development and therapeutic strategies against viral infections and autoimmune diseases. TLR7 is expressed in various immune cells, and its activation leads to the production of pro-inflammatory cytokines and type I interferons, essential for antiviral defense. Moreover, TLR7's relevance has been underscored in studies relating to the pathogenesis of systemic lupus erythematosus (SLE), where its overactivation is linked to autoimmunity. Investigating TLR7 in the context of recombinant protein studies allows for a deeper understanding of its structure-function relationship, enabling the design of novel immunotherapeutics that can modulate TLR7 activity for enhanced immune responses. As researchers continue to explore TLR7's mechanisms and interactions, the development of TLR7-based vaccines and adjuvants presents a promising avenue to improve immune activation and combat various infectious and autoimmune disorders. The recombinant expression of TLR7 in appropriate models further facilitates the study of its signaling pathways and interaction with ligands, providing insights that could lead to innovative treatments and preventive measures in immunology.